Abstract
The effects of tripelennamine on place preference conditioning in rats with pentazocine were investigated. Pentazocine at a dose of 2 mg/kg (IP) slightly, but not significantly, induced a place preference. Concurrent dosing of pentazocine (2 mg/kg, IP) and tripelennamine (2.5 mg/kg, SC) significantly and prominently produced a place preference, although administration of tripelennamine (2.5 mg/kg, SC) alone did not. Chronic infusion of a dopamine D1 receptor antagonist, SCH23390 (1.0 mg/kg/day) during conditioning abolished the appetitive effect of pentazocine potentiated by the combination with tripelennamine. In conclusion, it is suggested that the dopaminergic system, especially at the D1 receptor, plays an important role in the potentiation effect of tripelennamine on the pentazocine-induced place preference.
Similar content being viewed by others
References
Bergman J, Spealman RD (1986) Some behavioral effects of histamine H1 antagonists in squirrel monkeys. J Pharmacol Exp Ther 239:104–110
Butch AJ, Yokel RA, Sigell LT, Hanenson IB, Nelson ED (1979) Abuse and pulmonary complications of injecting pentazocine and tripelennamine tablets. Clin Toxicol 14:301–306
Evans SM, Johanson CE (1989) Discriminative stimulus properties of histamine H1-antagonists in animals trained to discriminate d-amphetamine or pentobarbital. J Pharmacol Exp Ther 250:779–786
Lange WR, Jasinski DR (1984) The clinical pharmacology of pentazocine and tripelennamine (T's and blues). Problems of drug dependence. Adv Alcohol Subst Abuse 5:71–83
Lahmeyer HW, Steingold RG (1980) Pentazocine and tripelennamine: a drug abuse epidemic? Int J Addict 15:1219–1232
Mucha RF, Herz A (1985) Motivational properties of kappa and mu-opioid receptor agonists studied with place and taste preference conditioning. Psychopharmacology 86:274–280
Mucha RF, Iversen SD (1984) Reinforcing properties of morphine and naloxone revealed by conditioned place preference: a procedural examination. Psychopharmacology 82:241–247
Poklis A, Mackell MA (1982) Pentazocine and tripelennamine (T's and blues) abuse: toxicological finding in 39 cases. J Anal Toxicol 6:109–114
Poklis A, Whyatt PL (1980) Current trends in the abuse of pentazocine and tripelennamine; the metropolitan St. Louis experience. J Forensic Sci 25:72–78
Shippenberg TS, Herz A (1987) Place preference conditioning reveals the involvement of D1-dopamine receptors in the motivational properties of μ- and κ-opioid agonists. Brain Res 436:169–172
Showalter CV (1980) T's and Blues-Abuse of pentazocine and tripelennamine. JAMA 224:1224–1225
Showalter CV, Moore L (1978) Abuse of pentazocine and tripelennamine. JAMA 239:1610–1612
Suzuki T, Masukawa Y, Misawa M (1990) Drug interactions in the reinforcing effects of over-the-counter cough syrups. Psychopharmacology 102:438–442
Tagashira E, Kachur JF, Carter WH Jr, Dewey WL (1984) Pentazocine-tripelennamine (“T's and Blues”) substitution studies in morphine-dependent rodents. J Pharmacol Exp Ther 231:97–101
Yeh SY (1985) Potentiation of pentazocine analgesia by tripelennamine in the rat. J Pharmacol Exp Ther 235:683–689
Yeh SY, Todd GD, Jonson RE, Gorodetzky CW, Lange WR (1986) The pharmacokinetics of pentazocine and tripelennamine. Clin Pharmacol Ther 39:669–676
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Suzuki, T., Masukawa, Y., Shiozaki, Y. et al. Potentiation of pentazocine conditioned place preference by tripelennamine in rats. Psychopharmacology 105, 9–12 (1991). https://doi.org/10.1007/BF02316857
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02316857